A detailed history of Cwm, LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 111 shares of VERA stock, worth $3,356. This represents 0.0% of its overall portfolio holdings.

Number of Shares
111
Previous 104 6.73%
Holding current value
$3,356
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 15, 2025

BUY
$19.25 - $28.96 $134 - $202
7 Added 6.73%
111 $3,000
Q2 2025

Jul 25, 2025

SELL
$18.86 - $32.0 $2,319 - $3,936
-123 Reduced 54.19%
104 $2,000
Q1 2025

May 01, 2025

BUY
$24.02 - $43.22 $4,876 - $8,773
203 Added 845.83%
227 $5,000
Q4 2024

Feb 04, 2025

BUY
$38.64 - $49.75 $386 - $497
10 Added 71.43%
24 $1,000
Q3 2024

Oct 08, 2024

BUY
$34.09 - $46.71 $136 - $186
4 Added 40.0%
14 $1,000
Q2 2024

Jul 09, 2024

BUY
$33.72 - $48.82 $303 - $439
9 Added 900.0%
10 $0
Q1 2024

Apr 05, 2024

BUY
$14.91 - $49.14 $14 - $49
1 New
1 $0

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $818M
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.